eFFECTOR Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.17 | -$2.17 | -$2.17 |
| Q2 2024 | 1 | -$1.74 | -$1.74 | -$1.74 |
| Q3 2024 | 1 | -$1.54 | -$1.54 | -$1.54 |
| Q4 2024 | 1 | -$0.90 | -$0.90 | -$0.90 |
eFFECTOR Therapeutics, Inc. Earnings Date And Information
eFFECTOR Therapeutics, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-4.25 earnings per share for the quarter, missing analysts' consensus estimates of $-2.02 by $2.23. The company had revenue of 0 for the quarter and had revenue of 0 for the year. eFFECTOR Therapeutics, Inc. has generated $-16 earnings per share over the last year ($-16.37 diluted earnings per share) and currently has a price-to-earnings ratio of -0. eFFECTOR Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based on prior year's report dates.
eFFECTOR Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/09/2024 | Q1 2024 | -$2.17 | -$2.16 | 0.01 | $0 | $0 |
| 03/26/2024 | Q4 2023 | -$3.42 | $162,000 | |||
| 11/13/2023 | Q3 2023 | -$3.25 | -$3.36 | -0.11 | $0 | |
| 08/08/2023 | Q2 2023 | -$4.75 | -$4.37 | 0.38 | $0 | |
| 05/09/2023 | Q1 2023 | -$5.50 | -$5.96 | -0.46 | $0 | |
| 03/08/2023 | Q4 2022 | -$4.50 | -$5.57 | -1.07 | $664,400 | $675,000 |
| 11/07/2022 | Q3 2022 | -$6.75 | -$5.80 | 0.95 | $0 | |
| 08/09/2022 | Q2 2022 | -$4.50 | -$4.20 | 0.3 | $2.01 M | |
| 05/10/2022 | Q1 2022 | -$8.00 | $1.77 | 9.77 | $280,000 | $0 |
| 03/16/2022 | Q4 2021 | -$6.25 | $11.79 | 18.04 | $100,000 | $1.43 M |
| 11/08/2021 | Q3 2021 | -$0.20 | $5.50 | 5.7 | $427,000 | |
| 08/12/2021 | Q2 2021 | -$6.15 | $692,000 | |||
| 06/03/2021 | Q1 2021 | -$11.00 | $0 | |||
| 03/29/2021 | Q4 2020 | -$0.66 | $42,000 | |||
| 09/29/2020 | Q3 2020 | -$12.71 | $574,000 | |||
| 06/29/2020 | Q2 2020 | $134.79 | $15.06 M | |||
| 03/30/2020 | Q1 2020 | $13.34 | $26.33 M |
eFFECTOR Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is eFFECTOR Therapeutics, Inc.'s earnings date?
eFFECTOR Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates.
-
How can I listen to eFFECTOR Therapeutics, Inc.'s earnings conference call?
The conference call for eFFECTOR Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read eFFECTOR Therapeutics, Inc.'s conference call transcript?
The conference call transcript for eFFECTOR Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does eFFECTOR Therapeutics, Inc. generate each year?
eFFECTOR Therapeutics, Inc. (:EFTR) has a recorded net income of $0. eFFECTOR Therapeutics, Inc. has generated $-16.37 earnings per share over the last four quarters.
-
What is eFFECTOR Therapeutics, Inc.'s price-to-earnings ratio?
eFFECTOR Therapeutics, Inc. (:EFTR) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.
